A PIONEERING medical firm which develops techniques to boost the effectiveness of chemotherapy has raised almost £75 million by floating on the stock market.
Edinburgh-based NuCana, which began trading yesterday on the NASDAQ stock market in New York, will use the windfall to fund further clinical trials and expand in the capital.
More here: http://www.heraldscotland.com/news/15565116
